,level_0,pmid,rpsid,pmidlink,components_type,rna_id,rna_id_interface,rnas,rna_length,rna_sequence,rna_classification,source,protein_sequence,protein_name,protein_region,protein_modification,protein_sequence_length,Uniprot ID,mark,link,IDR,low complexity domain,In_vitrovivo,solute_concentration,salt_concentration,buffer,temperature,incubation_time,other_requirement,detection_method,morphology,description,rna_length_num
0,14,PMID: 22398450,RNAPS0000051,https://pubmed.ncbi.nlm.nih.gov/22398450,RNA + protein,-,-,(UCUCUAAAAA)5,50nt,UCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAAUCUCUAAAAA,repeat RNA,-,"sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1|length=531aa|residues=1-531
MDGIVPDIAVGTKRGSDELFSTCVTNGPFIMSSNSASAANGNDSKKFKGDSRSAGVPSRV
IHIRKLPIDVTEGEVISLGLPFGKVTNLLMLKGKNQAFIEMNTEEAANTMVNYYTSVTPV
LRGQPIYIQFSNHKELKTDSSPNQARAQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQ
SPVLRIIVENLFYPVTLDVLHQIFSKFGTVLKIITFTKNNQFQALLQYADPVSAQHAKLS
LDGQNIYNACCTLRIDFSKLTSLNVKYNNDKSRDYTRPDLPSGDSQPSLDQTMAAAFGLS
VPNVHGALAPLAIPSAAAAAAAAGRIAIPGLAGAGNSVLLVSNLNPERVTPQSLFILFGV
YGDVQRVKILFNKKENALVQMADGNQAQLAMSHLNGHKLHGKPIRITLSKHQNVQLPREG
QEDQGLTKDYGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVSEEDLKVLFSSNGGV
VKGFKFFQKDRKMALIQMGSVEEAVQALIDLHNHDLGENHHLRVSFSKSTI",PTBP1,-,-,531aa(1-531),P26599,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0970,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0010,http://db.phasep.pro/browse/",-,"[32-44],[162-179],[306-335]",In vitro,136 µM [PTBP1];|80 µM RNA,"170 mM NaCl, 30 mM KCl, 1 mM MgCl2","170 mM NaCl, 30 mM KCl, 1 mM MgCl2",RT,"imme diately,> 2day s",other_molecular:1 mM ATP,Differential interference contrast microscopy,liquid,"Analogous droplets were also observed for an unrelated SH35-ligand5 pair and for the tetravalent RNA binding protein PTB interacting with an RNA oligonucleotide. Thus, liquid-liquiddemixing phase transitions may occur in many multivalent intracellular systems.",50
1,219,PMID: 28562589,RNAPS0000353,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CAG)10,30nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",30
2,220,PMID: 28562589,RNAPS0000354,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CAG)20,60nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",60
3,221,PMID: 28562589,RNAPS0000356,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CUG)20,60nt,CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",60
4,222,PMID: 28562589,RNAPS0000357,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CAG)31,93nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",93
5,223,PMID: 28562589,RNAPS0000358,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CUG)31,93nt,CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",93
6,224,PMID: 28562589,RNAPS0000359,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CAG)47,141nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",141
7,225,PMID: 28562589,RNAPS0000360,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CUG)47,141nt,CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with  this valency dependence, we found that the formation of CAG/CUG  RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c).  The intermolecular interactions between the transcripts potentially  could be competed out by shorter complementary antisense oligonucleotides (ASO).",141
8,227,PMID: 28562589,RNAPS0000114,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CAG)66,198nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with this valency dependence, we found that the formation of CAG/CUG RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c). The intermolecular interactions between the transcripts potentially could be competed out by shorter complementary antisense oligonucleotides (ASO).",198
9,228,PMID: 28562589,RNAPS0000115,https://pubmed.ncbi.nlm.nih.gov/28562589,RNA,-,-,(CUG)66,198nt,CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,25 nM RNA;|10mM[Tris][DNA],10mM MgCl2 100mM NaCl,pH7.0,RT,2 min,-,Confocal microscopy,liquid,"Consistent with this valency dependence, we found that the formation of CAG/CUG RNA clusters occurred only with more than 30 triplet repeats (Fig. 1c). The intermolecular interactions between the transcripts potentially could be competed out by shorter complementary antisense oligonucleotides (ASO).",198
10,229,PMID: 28562589,RNAPS0000116,https://pubmed.ncbi.nlm.nih.gov/28562589,Undefined,-,-,(CAG)120,360nt,CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,"sp|Q07955|SRSF1_HUMAN Serine/arginine-rich splicing factor 1 OS=Homo sapiens OX=9606 GN=SRSF1 PE=1 SV=2
MSGGGVIRGPAGNNDCRIYVGNLPPDIRTKDIEDVFYKYGAIRDIDLKNRRGGPPFAFVE
FEDPRDAEDAVYGRDGYDYDGYRLRVEFPRSGRGTGRGGGGGGGGGAPRGRYGPPSRRSE
NRVVVSGLPPSGSWQDLKDHMREAGDVCYADVYRDGTGVVEFVRKEDMTYAVRKLDNTKF
RSHEGETAYIRVKVDGPRSPSYGRSRSRSRSRSRSRSRSNSRSRSYSPRRSRGSPRYSPR
HSRSRSRT",SRSF1,-,-,248aa(1-248),Q07955,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1134,"[97-104],[106-106],[107-120],[196-248]","[72-85],[89-119],[196-247]",In vivo,-,-,-,-,-,cell:U2OS cell,Confocal microscopy,-,Upon induction of 47×CAG or 120×CAG RNA transcription numerous nuclear foci appeared as early as 2 h after induction. The number of foci per nucleus increased with higher levels of RNA induction.,360
11,268,PMID: 29262335,RNAPS0000131,https://pubmed.ncbi.nlm.nih.gov/29262335,RNA + proteins,-,-,(AAAACC)4,24nt,AAAACCAAAACCAAAACCAAAACC,repeat RNA,-,-,U2OS lysate,-,-,-,-,-,-,-,-,In vitro,0-1.5µM [(A4C2)4];|0.1-10µM U2OS lysate,75-200 mM NaCl,-,-,60 min,-,Fluorescence microscopy,solute,"Fluorescently labeled r(G4C2)4 promotes microscopically visible foci in cell lysates, but not in buffer controls. These foci form in a concentration-dependent manner. rScram also forms microscopically visible foci in cell lysate yet to a lesser extent than r(G4C2)4. Neither r(A4C2)4 nor r(C4G2)4 form foci even at higher concentrations.",24
12,269,PMID: 29262335,RNAPS0000132,https://pubmed.ncbi.nlm.nih.gov/29262335,RNA + proteins,-,-,r(GGGGCC)4,24nt,GGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,-,U2OS lysate,-,-,-,-,-,-,-,-,In vitro,0.1-10µM [(G4C2)4];|0.1-10µM U2OS lysate,75-200 mM NaCl,-,-,60 min,crowding agent:with or without 0-5% Ficoll,Fluorescence microscopy,liquid,"Fluorescently labeled r(G4C2)4 promotes microscopically visible foci in cell lysates, but not in buffer controls. These foci form in a concentration-dependent manner. rScram also forms microscopically visible foci in cell lysate yet to a lesser extent than r(G4C2)4. Neither r(A4C2)4 nor r(C4G2)4 form foci even at higher concentrations.",24
13,270,PMID: 29262335,RNAPS0000133,https://pubmed.ncbi.nlm.nih.gov/29262335,RNA + proteins,-,-,r(CCCCGG)4,24nt,CCCCGGCCCCGGCCCCGGCCCCGG,repeat RNA,-,-,U2OS lysate,-,-,-,-,-,-,-,-,In vitro,0-1.0µM [(C4G2)4];|0.1-10µM U2OS lysate,75-200 mM NaCl,-,-,60 min,-,Fluorescence microscopy,solute,"Fluorescently labeled r(G4C2)4 promotes microscopically visible foci in cell lysates, but not in buffer controls. These foci form in a concentration-dependent manner. rScram also forms microscopically visible foci in cell lysate yet to a lesser extent than r(G4C2)4. Neither r(A4C2)4 nor r(C4G2)4 form foci even at higher concentrations.",24
14,271,PMID: 29262335,RNAPS0000134,https://pubmed.ncbi.nlm.nih.gov/29262335,Undefined,-,-,r(GGGGCC)11,66nt,GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ;

sp|P55884|EIF3B_HUMAN Eukaryotic translation initiation factor 3 subunit B OS=Homo sapiens OX=9606 GN=EIF3B PE=1 SV=3
MQDAENVAVPEAAEERAEPGQQQPAAEPPPAEGLLRPAGPGAPEAAGTEASSEEVGIAEA
GPESEVRTEPAAEAEAASGPSESPSPPAAEELPGSHAEPPVPAQGEAPGEQARDERSDSR
AQAVSEDAGGNEGRAAEAEPRALENGDADEPSFSDPEDFVDDVSEEELLGDVLKDRPQEA
DGIDSVIVVDNVPQVGPDRLEKLKNVIHKIFSKFGKITNDFYPEEDGKTKGYIFLEYASP
AHAVDAVKNADGYKLDKQHTFRVNLFTDFDKYMTISDEWDIPEKQPFKDLGNLRYWLEEA
ECRDQYSVIFESGDRTSIFWNDVKDPVSIEERARWTETYVRWSPKGTYLATFHQRGIALW
GGEKFKQIQRFSHQGVQLIDFSPCERYLVTFSPLMDTQDDPQAIIIWDILTGHKKRGFHC
ESSAHWPIFKWSHDGKFFARMTLDTLSIYETPSMGLLDKKSLKISGIKDFSWSPGGNIIA
FWVPEDKDIPARVTLMQLPTRQEIRVRNLFNVVDCKLHWQKNGDYLCVKVDRTPKGTQGV
VTNFEIFRMREKQVPVDVVEMKETIIAFAWEPNGSKFAVLHGEAPRISVSFYHVKNNGKI
ELIKMFDKQQANTIFWSPQGQFVVLAGLRSMNGALAFVDTSDCTVMNIAEHYMASDVEWD
PTGRYVVTSVSWWSHKVDNAYWLWTFQGRLLQKNNKDRFCQLLWRPRPPTLLSQEQIKQI
KKDLKKYSKIFEQKDRLSQSKASKELVERRRTMMEDFRKYRKMAQELYMEQKNERLELRG
GVDTDELDSNVDDWEEETIEFFVTEEIIPLGNQE",G3BP1;|EIF3B,-;|-,-;|-,466aa;|814aa(1-814),Q13283;P55884,"DrLLPS,PhaSepDB;DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0700,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466];|-","[142-167],[184-213],[291-307],[421-450];|-",In vivo,-,-,-,RT,-,organelle:stress granule;cell:U2OS cell,Fluorescence microscopy,-,"Transfection of in-vitro-transcribed rG4C2 into U2OS cells promotes G3BP1-positive granules in a repeat length dependent manner. Transfection of r(G4C2)4 promotes SG assembly in wild-type MEFs, but not in MEFs containing the eIF2a-S51A mutation, indicating eIF2a phosphorylation is required for rG4C2 induced SG assembly.",66
15,272,PMID: 29262335,RNAPS0000072,https://pubmed.ncbi.nlm.nih.gov/29262335,Undefined,-,-,r(GGGGCC)38,228nt,GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ",G3BP1;|EIF3B,-;|-,-;|-,466aa;|814aa(1-814),Q13283;P55884,"DrLLPS,PhaSepDB;DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0700,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466];|-","[142-167],[184-213],[291-307],[421-450];|-",In vivo,-,-,-,RT,-,organelle:stress granule;cell:U2OS cell,Fluorescence microscopy,-,"Transfection of in-vitro-transcribed rG4C2 into U2OS cells promotes G3BP1-positive granules in a repeat length dependent manner. Transfection of r(G4C2)4 promotes SG assembly in wild-type MEFs, but not in MEFs containing the eIF2a-S51A mutation, indicating eIF2a phosphorylation is required for rG4C2 induced SG assembly.",228
16,273,PMID: 29262335,RNAPS0000135,https://pubmed.ncbi.nlm.nih.gov/29262335,Undefined,-,-,r(GGGGCC)28,168nt,GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ",G3BP1;|EIF3B,-;|-,-;|-,466aa;|814aa(1-814),Q13283;P55884,"DrLLPS,PhaSepDB;DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0700,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466];|-","[142-167],[184-213],[291-307],[421-450];|-",In vivo,-,-,-,RT,-,organelle:stress granule;cell:U2OS cell,Fluorescence microscopy,-,"Transfection of in-vitro-transcribed rG4C2 into U2OS cells promotes G3BP1-positive granules in a repeat length dependent manner. Transfection of r(G4C2)4 promotes SG assembly in wild-type MEFs, but not in MEFs containing the eIF2a-S51A mutation, indicating eIF2a phosphorylation is required for rG4C2 induced SG assembly.",168
17,274,PMID: 29262335,RNAPS0000136,https://pubmed.ncbi.nlm.nih.gov/29262335,Undefined,-,-,r(GGGGCC)75,450nt,GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ",G3BP1;|EIF3B,-;|-,-;|-,466aa;|814aa(1-814),Q13283;P55884,"DrLLPS,PhaSepDB;DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0700,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466];|-","[142-167],[184-213],[291-307],[421-450];|-",In vivo,-,-,-,RT,-,organelle:stress granule;cell:U2OS cell,Fluorescence microscopy,-,"Transfection of in-vitro-transcribed rG4C2 into U2OS cells promotes G3BP1-positive granules in a repeat length dependent manner. Transfection of r(G4C2)4 promotes SG assembly in wild-type MEFs, but not in MEFs containing the eIF2a-S51A mutation, indicating eIF2a phosphorylation is required for rG4C2 induced SG assembly.",450
18,701,PMID: 32301603,RNAPS0000381,https://pubmed.ncbi.nlm.nih.gov/32301603,RNA,-,-,(CAG)8,24nt,CAGCAGCAGCAGCAGCAGCAGCAG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,10 µM [(CAG)8],"8 mM MgCl2, 60 mM KCl","40 mM Tris-HCl (pH 7.6), 0.05% Tween 20",37˚C,≤ 9 h,crowding agent:0wt % PEG8000 or 10 wt % PEG8000,Fluorescence microscopy,liquid,"Unexpectedly, two different trends closely related to the RNA structures were obtained. For repeats with hairpin structures that included r(CAG)8 and r(CUG)8, a few RNAs gelled to form large particles in the absence of PEG8000.",24
19,702,PMID: 32301603,RNAPS0000382,https://pubmed.ncbi.nlm.nih.gov/32301603,RNA,-,-,(CUG)8,24nt,CUGCUGCUGCUGCUGCUGCUGCUG,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,10 µM [(CUG)8],"8 mM MgCl2, 60 mM KCl","40 mM Tris-HCl (pH 7.6), 0.05% Tween 20",37˚C,≤ 9 h,crowding agent:0wt % PEG8000 or 10 wt % PEG8000,Fluorescence microscopy,liquid,"Unexpectedly, two different trends closely related to the RNA structures were obtained. For repeats with hairpin structures that included r(CAG)8 and r(CUG)8, a few RNAs gelled to form large particles in the absence of PEG8000.",24
20,703,PMID: 32301603,RNAPS0000383,https://pubmed.ncbi.nlm.nih.gov/32301603,RNA,-,-,(GGGGCC)8,48nt,GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,10 µM [(GGGGCC)8],"8 mM MgCl2, 60 mM KCl","40 mM Tris-HCl (pH 7.6), 0.05% Tween 20",37˚C,≤ 9 h,crowding agent:0wt % PEG8000 or 10 wt % PEG8000,Fluorescence microscopy,liquid,"Unexpectedly, two different trends closely related to the RNA structures were obtained. For repeats with hairpin structures that included r(CAG)8 and r(CUG)8, a few RNAs gelled to form large particles in the absence of PEG8000.",48
21,704,PMID: 32301603,RNAPS0000384,https://pubmed.ncbi.nlm.nih.gov/32301603,RNA,-,-,(GGGUUA)8,48nt,GGGUUAGGGUUAGGGUUAGGGUUAGGGUUAGGGUUAGGGUUAGGGUUA,repeat RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,10 µM [(GGGUUA)8],"8 mM MgCl2, 60 mM KCl","40 mM Tris-HCl (pH 7.6), 0.05% Tween 20",37˚C,≤ 9 h,crowding agent:0wt % PEG8000 or 10 wt % PEG8000,Fluorescence microscopy,liquid,"Unexpectedly, two different trends closely related to the RNA structures were obtained. For repeats with hairpin structures that included r(CAG)8 and r(CUG)8, a few RNAs gelled to form large particles in the absence of PEG8000.",48
22,831,PMID: 32995779,RNAPS0000438,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyAU,-,-,repeat RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5-5000 ng/µL [polyAU];|18.5 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Microscopy,solid,"Similar to polyC RNA, polyA and polyU RNA substrates produced spherical condensates at micromolar  concentrations of the N protein (Figure 2A). However, combining N protein with polyG that forms G quadruplexes or polyAU that forms base-pair interactions led to the formation of non-spherical condensates",
23,888,PMID: 33523882,RNAPS0000460,https://pubmed.ncbi.nlm.nih.gov/33523882,RNA + protein,-,-,(CGG)99,297nt,CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG,repeat RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1
MEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFPPPVGYNKDIN
ESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACDATYNEIVTIERLRSVNPNKP
ATKDTFHKIKLDVPEDLRQMCAKEAAHKDFKKAVGAFSVTYDPENYQLVILSINEVTSKR
AHMLIDMHFRSLRTKLSLIMRNEEASKQLESSRQLASRFHEQFIVREDLMGLAIGTHGAN
IQQARKVPGVTAIDLDEDTCTFHIYGEDQDAVKKARSFLEFAEDVIQVPRNLVGKVIGKN
GKLIQEIVDKSGVVRVRIEAENEKNVPQEEEIMPPNSLPSNNSRVGPNAPEEKKHLDIKE
NSTHFSQPNSTKVQRVLVASSVVAGESQKPELKAWQGMVPFVFVGTKDSIANATVLLDYH
LNYLKEVDQLRLERLQIDEQLRQIGASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRG
HGRRGPGYTSGTNSEASNASETESDHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRG
QGGRGRGGGFKGNDDHSRTDNRPRNPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSS
EGSRLRTGKDRNQKKEKPDSVDGQQPLVNGVP",FMR1,-,-,632aa(1-632),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/","[281-422],[443-515],[516-632]","[492-504],[527-549]",In vitro,20 ng/µl [(CGG)99];|9 µM [FMRpolyG],"25 mM NaCl, 10 mM MgCl2","10 mM tris-HCl buffer pH 7.5,12% (w/v) glycerol",23˚C,1 h,-,FRAP,liquid,We next investigated whether PpIX affects the LLPS of FMRpolyG  in vitro. The phase-separated liquid droplets and hydrogels of com plexes of fluorescein-FMRpolyG and CX rhodamine–CGG99 formed  substantially smaller droplets after PpIX treatment compared to un treated controls,297
24,891,PMID: 33523882,RNAPS0000462,https://pubmed.ncbi.nlm.nih.gov/33523882,Undefined,-,-,(CGG)8,24nt,CGGCGGCGGCGGCGGCGGCGGCGG,repeat RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1
MEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFPPPVGYNKDIN
ESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACDATYNEIVTIERLRSVNPNKP
ATKDTFHKIKLDVPEDLRQMCAKEAAHKDFKKAVGAFSVTYDPENYQLVILSINEVTSKR
AHMLIDMHFRSLRTKLSLIMRNEEASKQLESSRQLASRFHEQFIVREDLMGLAIGTHGAN
IQQARKVPGVTAIDLDEDTCTFHIYGEDQDAVKKARSFLEFAEDVIQVPRNLVGKVIGKN
GKLIQEIVDKSGVVRVRIEAENEKNVPQEEEIMPPNSLPSNNSRVGPNAPEEKKHLDIKE
NSTHFSQPNSTKVQRVLVASSVVAGESQKPELKAWQGMVPFVFVGTKDSIANATVLLDYH
LNYLKEVDQLRLERLQIDEQLRQIGASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRG
HGRRGPGYTSGTNSEASNASETESDHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRG
QGGRGRGGGFKGNDDHSRTDNRPRNPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSS
EGSRLRTGKDRNQKKEKPDSVDGQQPLVNGVP",FMR1,-,-,153(1-153),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/",-,-,In vivo,-,-,-,RT,-,cell:Neuro-2a cells,"FISH,Confocal Laser scanning microscopy",-,"In green fluorescent protein (GFP)–tagged FL- and PolyG-expressing cells, we observed strongly aggregated GFP-positive inclusions that colocalized with RNA foci labeled with a CCG8 antisense probe and with transfected CX rhodamine–labeled CGG99 RNA.",24
25,904,PMID: 33621982,RNAPS0000471,https://pubmed.ncbi.nlm.nih.gov/33621982,RNA + protein,-,-,(UUUUUACUCCAA)4+UUUUUACUCC,58nt,UUUUUACUCCAAUUUUUACUCCAAUUUUUACUCCAAUUUUUACUCCAAUUUUUACUCC,repeat RNA,-,"sp|P31483|TIA1_HUMAN Nucleolysin TIA-1 isoform p40 OS=Homo sapiens OX=9606 GN=TIA1 PE=1 SV=3
MEDEMPKTLYVGNLSRDVTEALILQLFSQIGPCKNCKMIMDTAGNDPYCFVEFHEHRHAA
AALAAMNGRKIMGKEVKVNWATTPSSQKKDTSSSTVVSTQRSQDHFHVFVGDLSPEITTE
DIKAAFAPFGRISDARVVKDMATGKSKGYGFVSFFNKWDAENAIQQMGGQWLGGRQIRTN
WATRKPPAPKSTYESNTKQLSYDEVVNQSSPSNCTVYCGGVTSGLTEQLMRQTFSPFGQI
MEIRVFPDKGYSFVRFNSHESAAHAIVSVNGTTIEGHVVKCYWGKETLDMINPVQQQNQI
GYPQPYGQWGQWYGNAQQIGQYMPNGWQVPAYGMYGQAWNQQGFNQTQSSAPWMGPNYGV
QPPQGQNGSMLPNQPSGYRVAGYETQ",TIA-1,-,-,386aa(1-386),P31483,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P31483,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0303,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0007,http://db.phasep.pro/browse/",[354-386],"[59-65],[82-104]",In vitro,0.25 µM [RNA];|2.5 µM [TIA-1],50 mM NaCl,"20 mM HEPES
pH 7, 40 mM Arginine",RT,10 min,-,Turbidity measurement,liquid,"To directly test the ability of the oligonucleotide con centration with specific binding sites to modulate TIA-1 condensation, we varied the concentration of TC5 between 0.125 and 5  M and monitored spontaneous phase sepa ration and fibril formation over time of TIA-1 at 2.5  M",58
26,964,PMID: 32234784,RNAPS0000526,https://pubmed.ncbi.nlm.nih.gov/32234784,RNA + protein,-,-,(UG)12,24nt,UGUGUGUGUGUGUGUGUGUGUGUG,repeat RNA,-,"sp|Q14011|CIRBP_HUMAN Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1|residue=RGG 90-137
RGYRGGSAGGRGFFRGGRGRGRGFSRGGGDRGYGGNRFESRSGGYGG",CIRBP,RGG,-,47aa(90-137),Q14011,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0652,http://db.phasep.pro/browse/",[90-137],"[90-125],[130-137]",In vitro,30 µM [CIRBP];|10 µM (UG)12 RNA,75 mM NaCl,"20 mM Na2HPO4/NaH2PO4 pH 7.5,1 mM DTT,2.5% glycerol",25℃,≤ 30 min,-,Differential interference contrast microscopy,liquid,DIC microscopy showed that CIRBPRGG formed liquid-like condensates in the presence of RNA similar to the full-length protein.,24
